Exelixis stock falls as FDA extends zanzalintinib review
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
Find insight on Apple, CyberAgent, Adobe and more in the latest Market Talks covering Technology, Media and Telecom.
Inflation stands more than a percentage point above the Fed's target rate of 2%.